New Zealand Resident Visa Health Rules Change: Hepatitis B and C No Longer an Automatic Bar From August 3

Study Abroad Expert | Updated On - Aug 10, 2026

Immigration New Zealand has removed Hepatitis B and Hepatitis C from its resident visa high-cost health conditions list from August 3, 2026. The shift matters to Indian graduates aiming for New Zealand permanent residency after their studies. INZ confirmed the update on August 7, 2026, citing treatment costs now well below the significant cost threshold. The old rule triggered an automatic adverse health assessment on any positive diagnosis.

Resident visa applications lodged on or after August 3, 2026 no longer fail automatically on a Hepatitis B or C diagnosis, per INZ.
Medical assessors will weigh each case on individual health, treatment plan and expected care cost, tested against the NZD 81,000 significant cost threshold.
PHARMAC funding of newer antiviral therapies is the reason INZ cites for pulling expected treatment costs under that threshold.

The change sits inside a broader August update that also refined wording on psychiatric illness, autoimmune conditions and renal or hepatic disorders. Indian students remain one of the largest cohorts eyeing New Zealand’s study-to-residence pipeline.

What has NOT changed: the acceptable standard of health requirement itself stands. Applicants with hepatitis B or C still disclose their history, complete any medical INZ requests and get assessed on individual circumstances. INZ is explicit that the ability to pay privately, health insurance or financial support from relatives does not override the health criteria.

Also Read,

What Changes for Hepatitis B and C Applicants From August 3

Until now, a Hepatitis B or C diagnosis flipped the health test to an automatic fail. INZ classified both conditions as high-cost, so the case was closed before individual factors were read. That listing is now gone for resident visa files.

From August 3, 2026, medical assessors read the applicant’s own clinical file. They check current viral load, treatment status, likely progression and expected treatment expense. The result depends on those numbers, not on the label alone.

Important Distinction: Delisting is not a free pass. Applicants still have to complete the full immigration medical, chest X-ray, and blood work. Advanced liver disease or complications tied to Hepatitis can still push a case over the NZD 81,000 line and draw an adverse assessment.

Why Immigration New Zealand Softened the Health Test

INZ has said the delisting reflects the reduced cost of managing both conditions in New Zealand’s public system. Direct-acting antivirals now clear most Hepatitis C infections. Hepatitis B is managed with long-term antivirals that PHARMAC subsidises. The significant cost threshold sits at NZD 81,000. That is the ceiling for expected treatment or special education spend across five years, or across the predicted course of the condition. It was lifted from NZD 41,000 in September 2022 and covers every applicant in the file.

At the current market rate, NZD 81,000 works out to roughly ₹42 lakh. Standard Hepatitis B or C care in New Zealand now falls well under that number, INZ says, which is what removed the automatic bar.

How Indian Graduates Reach the Resident Visa

Most Indian students in New Zealand land on a student visa, then move to a Post-Study Work Visa, and finally to residence. The health test hits hardest at the residence stage. The August 3 change lives in that final gate.

Stage	Visa	Health Test Level
Study	Fee Paying Student Visa	Chest X-ray, medical for stays over 12 months
Work after study	Post-Study Work Visa (up to 3 years)	Same tests carry over if still valid
Residence	Skilled Migrant Category Resident Visa	Full acceptable standard of health assessment

An Indian graduate switching from a Post-Study Work Visa to the Skilled Migrant Category is the primary beneficiary. A Hepatitis B or C diagnosis picked up in New Zealand no longer ends the PR file at the first hurdle.

What it means for Indian Students: Hepatitis B carrier rates in India sit near 3 to 4 percent of adults on published health data. Under the old rule, any of those carriers ran into an automatic residence refusal. The August 3 shift restores a real path to PR for that group.

Also Read,

What Else Changed in the August 2026 Health Rules Update

The same update refined the wording on three other condition groups. INZ said the changes tighten clarity for medical assessors and applicants.

Psychiatric illness: updated language on how severity and treatment history are read.
Autoimmune disease: clarified which cases trigger a full cost assessment.
Renal and hepatic disorders: refined thresholds for what counts as a significant cost concern.

None of these were delisted. The rewording sets clearer expectations on documents and specialist reports needed at the medical stage.

The pattern behind the change: New Zealand removed HIV from the same high cost list in October 2021, moving those applicants to case by case assessment. Hepatitis follows the identical logic, replacing the old auto fail wording that caught surface antigen positive hepatitis B and RNA positive hepatitis C cases meeting treatment criteria.

How Should Indian Students Prepare the Health Certificate?

The medical is done by a panel physician approved by INZ. Applicants staying over 12 months for study need a chest X-ray and general medical. Residence applicants complete a fuller battery, including blood work. Panel doctor lists sit on the INZ site by country. Reports upload directly into eMedical from the clinic. Fees are paid to the clinic, not to INZ, and vary by city.

Applicants already carrying a Hepatitis diagnosis should carry recent treatment notes, viral load reports and a specialist letter into the medical. Those documents help the INZ assessor read the case under the new individual-circumstance test. Indian graduates applying for residence from August 3, 2026 gain a real second look on Hepatitis B or C. The final call now rests on the clinical file, not on a listed label. The next stress point is the NZD 81,000 threshold, so treatment records will decide the outcome.

Action Plan for Indian Applicants

Confirm the resident visa file is lodged on or after August 3, 2026, so the new rule applies.
Book the immigration medical only with an INZ-approved panel physician listed on the official portal.
If diagnosed with Hepatitis B or C, gather the last 12 months of viral load reports, treatment notes and a specialist letter.
Ask the treating doctor for a written care plan and expected annual cost estimate, priced against the NZD 81,000 threshold.
Track the SMC or Green List route that matches your qualification before filing the residence application.

Keep an Eye On: INZ’s next scheduled review of the acceptable standard of health list, expected through 2027, may revisit other high-cost conditions. Indian applicants on the study-to-residence route should track further updates before locking in medicals.